65 related articles for article (PubMed ID: 8031544)
1. R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers.
Zusman RM; Hui KY; Nussberger J; Christensen DM; Higgins J; Carlson WD; Schoenfeld D; Haber E
Am J Hypertens; 1994 Apr; 7(4 Pt 1):295-301. PubMed ID: 8031544
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin inhibition in the conscious primate Macaca fascicularis.
Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E
Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
Nussberger J; Delabays A; De Gasparo M; Cumin F; Waeber B; Brunner HR; Ménard J
Hypertension; 1989 Jun; 13(6 Pt 2):948-53. PubMed ID: 2661435
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone.
Tree M; Szelke M; Leckie B; Atrash B; Donovan B; Hallett A; Jones DM; Lever AF; Morton JJ; Sueiras-Diaz J
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S49-52. PubMed ID: 2412013
[TBL] [Abstract][Full Text] [Related]
5. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
de Gasparo M; Cumin F; Nussberger J; Guyenne TT; Wood JM; Menard J
Br J Clin Pharmacol; 1989 May; 27(5):587-96. PubMed ID: 2667598
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
8. Combined renin and converting enzyme inhibition in rats.
Mento PF; Holt WF; Murphy WR; Wilkes BM
Hypertension; 1989 Jun; 13(6 Pt 2):741-8. PubMed ID: 2661429
[TBL] [Abstract][Full Text] [Related]
9. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P
Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
[TBL] [Abstract][Full Text] [Related]
10. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
Carey RM; Vaughan ED; Peach MJ; Ayers CR
J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
[TBL] [Abstract][Full Text] [Related]
11. Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
van den Meiracker AH; Admiraal PJ; Man in 't Veld AJ; Derkx FH; Ritsema van Eck HJ; Mulder P; van Brummelen P; Schalekamp MA
BMJ; 1990 Jul; 301(6745):205-10. PubMed ID: 2203486
[TBL] [Abstract][Full Text] [Related]
12. Inadequate suppression of angiotensin II modulates left ventricular structure in humans.
Schlaich MP; Schobel HP; Langenfeld MR; Hilgers K; Schmieder RE
Clin Nephrol; 1998 Mar; 49(3):153-9. PubMed ID: 9543596
[TBL] [Abstract][Full Text] [Related]
13. Renin--angiotensin antagonists and the regulation of blood pressure.
Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal renin inhibition increases renal function by an angiotensin II-dependent mechanism.
Siragy HM; Lamb NE; Rose CE; Peach MJ; Carey RM
Am J Physiol; 1988 Oct; 255(4 Pt 2):F749-54. PubMed ID: 3052111
[TBL] [Abstract][Full Text] [Related]
15. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
16. Rate of activation of renin-angiotensin-aldosterone axis and sodium intake in rats.
Holtzman E; Braley LM; Menachery A; Williams GH; Hollenberg NK
Am J Physiol; 1989 May; 256(5 Pt 2):H1311-5. PubMed ID: 2655479
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC
J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056
[TBL] [Abstract][Full Text] [Related]
18. H-77: a potent new renin inhibitor. In vitro and in vivo studies.
Szelke M; Leckie BJ; Tree M; Brown A; Grant J; Hallett A; Hughes M; Jones DM; Lever AF
Hypertension; 1982; 4(3 Pt 2):59-69. PubMed ID: 7040240
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
Burton J; Cody RJ; Herd JA; Haber E
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
[TBL] [Abstract][Full Text] [Related]
20. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
Wong PY; Talamo RC; Williams GH; Colman RW
J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
